StockGuru Trade Alert: Renhuang Pharmaceuticals Rated ‘Outperform’ Target Price $7.00 by Beacon Equity Research
Renhuang Pharmaceuticals Rated ‘Outperform’ Target Price $7.00 by Beacon Equity ResearchDALLAS–Renhuang Pharmaceuticals (OTCBB: RHGP) has been rated Outperform with a price target of $7.00 by Beacon Equity Research Analyst, Lisa Springer, CFA. The full report is available at http://www.BeaconEquityResearch.com. Anyone interested in receiving alerts regarding Renhuang Pharmaceuticals research should email members@beaconequityresearch.com with “RHGP” in the subject line. In the report, the analyst writes, “Renhuang Pharmaceuticals Inc. (RHGP) is a vertically integrated developer, manufacturer and distributor of high-quality nutraceutical, natural medicinal and bio-pharmaceutical products in mainland China. It offers three major product lines: Acanthopanax-based natural medicinal products, the Shark Power healthcare…